0001437749-22-022307.txt : 20220913
0001437749-22-022307.hdr.sgml : 20220913
20220913160744
ACCESSION NUMBER: 0001437749-22-022307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220909
FILED AS OF DATE: 20220913
DATE AS OF CHANGE: 20220913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosol Michael Stanley
CENTRAL INDEX KEY: 0001762349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 221240822
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-09-09
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001762349
Rosol Michael Stanley
4995 BRADENTON AVE., SUITE 240
DUBLIN
OH
43017
1
Chief Medical Officer
Common Stock
2022-09-09
4
A
0
28150
0
A
42725
D
Common Stock
2022-09-09
4
A
0
13000
0
A
55725
D
Common Stock
11320
I
Held by 401(k) Plan
The Reporting Person elected to receive stock in lieu of a cash bonus. The number of shares was determined based on the closing price on the date of grant, September 9, 2022.
Stock Issued under the Amended and Restated 2014 Stock Incentive Plan.
/s/ Erika L. Eves for Michael S. Rosol, by power of attorney
2022-09-13